eLife Review Time

ELife is unusual because the citation history still matters even though the journal no longer carries a current JIF.

For year-over-year citation data, see the elife citation metrics page.

The last listed JIF was down from 8.7 in 2021 to 7.6 in 2022, and then the journal was not listed from 2023 onward once Web of Science stopped indexing it fully. That means the old citation profile still says something about visibility, but the submission decision now turns much more on whether the reviewed-preprint model fits your paper and career context.

Under the new model, eLife doesn't reject papers after review. Instead:

1. Papers undergo initial assessment by a senior editor and reviewing editor

1. Papers deemed suitable are sent for full peer review

1. Reviews are published alongside the paper as a "reviewed preprint"

1. Each paper receives an assessment categorizing its significance and strength of evidence

1. Authors can revise based on reviews. Revised versions are published with updated reviews and assessments as appropriate

ELife doesn't review everything. The initial assessment filters papers that are outside scope, have fundamental methodological problems, or aren't suitable for the eLife audience. eLife reports a median of eight days to a decision when an article is not selected for review (2025), and the assessment serves a similar function to desk rejection at traditional journals, even though the later workflow is very different.

ELife uses a distinctive consultation process where reviewers discuss their assessments before the editorial assessment is finalized. This produces a more coherent, consolidated eLife Assessment than the independent reviewer reports at most journals. Reviewers see each other's reviews in an online consultation session, but each Public Review is still written by one reviewer.

Each reviewed preprint receives two ratings:

• Significance: Landmark, Fundamental, Important, Valuable, Useful

• Strength of evidence: Exceptional, Compelling, Convincing, Solid, Incomplete, Inadequate

A paper rated "Landmark / Exceptional" is equivalent to an enthusiastic acceptance at a traditional journal. A paper rated "Useful / Incomplete" is equivalent to a rejection with revision suggestions.

The ratings become part of the permanent record alongside the paper.

Initial assessment decline (median eight days): The editors didn't think the paper was suitable for eLife's review process. Not published as a reviewed preprint.

Faster-than-median review: Reviewers respond quickly, consultation is brief. The paper and reviews are published promptly.

Slower-than-median review: A reviewer is late or the consultation process reveals disagreements that need resolution. Not unusual.

Revision cycle (variable): Authors can revise at any time, and eLife asks to be told if a revision will take more than 12 months. Some revise in weeks, some take months. The original reviewed preprint remains published.

ELife's timeline makes sense only if you understand the new model as a publication-with-reviews workflow rather than a classic accept-reject workflow. The next useful questions are usually about fit, process, and whether the public-review model is strategically right for the paper:

• eLife submission process

• eLife citation metrics

• eLife pre-submission checklist

For eLife-targeted manuscripts, three patterns most consistently predict slow review at eLife. These are the same patterns our reviewers flag in pre-submission work. The named editorial-culture quirk: eLife uses public peer review with author-reviewer-editor consultation; manuscripts without explicit data-availability and code-availability statements extend revision.

Scope-fit ambiguity in the abstract. eLife editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (biological research evaluated on methodological rigor with public peer-review transparency). The named failure pattern: manuscripts without explicit data-availability and code-availability statements extend revision rounds. Check whether your abstract reads to eLife's scope →

Methods package incomplete for the journal's reviewer pool. eLife reviewers expect specific methodological detail. Preliminary findings without complete methodology extend reviewer consultation in elife's public-review model. Check if your methods package is reviewer-complete →

Reference-list and clean-citation failure mode. eLife staff perform quality and integrity checks on submissions, so confirm that no reference is a retracted paper. Check whether your reference list is clean against Crossref + Retraction Watch →

Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: Submit author instructions. Manuscript constraints: abstracts normally run 150 to 200 words, and there is no maximum length for Research Articles (eLife suggests keeping the main text under 5,000 words, excluding Materials and methods, References and figure legends).

We reviewed each of these constraints against current journal author guidelines (accessed 2026-10-09).

In our pre-submission review work with eLife-targeted manuscripts, the editorial-culture mismatch we see most often is that eLife uses public peer review with author-reviewer-editor consultation, and manuscripts without explicit data-availability and code-availability statements extend revision. The first-decision distribution is bimodal between manuscripts that clear eLife's scope-fit threshold quickly and those that get extended editorial-board consultation. Verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.

The main mistake is reading eLife's roughly three-month (96-day median) review cycle as if it were equivalent to a standard first-decision clock at another journal. It is not. At eLife, that window ends with a reviewed preprint and public assessment, not with the private yes-or-no decision most authors are used to.

That changes the strategic question for the author. The right question is not only "how fast is eLife?" It is "am I comfortable having the paper's first substantial critique become part of the public record on that timeline?" For some papers that is a feature. For others, it changes the journal choice entirely.

Across Manusights submission reviews for manuscripts considering eLife, three patterns generate the most consistent initial-assessment declines.

Authors treating the model as easier than a traditional journal. This is a common pattern in eLife manuscripts we review. The paper is good, but the submission logic assumes that transparent review will rescue a package that is still one experiment or one framing pass short of public exposure.

Claims that would attract a weak public evidence rating. eLife's current model makes the strength-of-evidence assessment part of the permanent record. Editors specifically screen whether the paper is ready for public review rather than private negotiation, and in our experience many eLife manuscripts we audit would face a weaker public assessment than the authors expect because the causal claim outruns the data package.

Field fit that is good science but weak eLife audience fit. The eLife model works best when the paper belongs in a life-science conversation that can read reviewed preprints on their own merits. Our review of eLife submissions repeatedly finds that some manuscripts are better served by a more conventional journal because the strongest audience is still evaluating papers through private accept-reject outcomes and journal-level shorthand.

The Manusights eLife readiness scan. This guide tells you what eLife's editors look for in triage, which eLife reports takes a median of eight days when an article is not selected for review. The review tells you whether your paper passes that check before you submit. We have reviewed manuscripts targeting eLife and peer venues; the named patterns below are the same ones the journal's handling editors and outside reviewers flag at the desk-screen and first-review stages.

Median 96 days from submission to a published Reviewed Preprint under eLife's public-review model (2025); eLife reports a median of eight days when an article is not selected for review. 60-day money-back guarantee. Your manuscript is not used for model training, and access is limited to the review workflow.

Published eLife review-time medians mask real variation. eLife reports a median of eight days for articles that are not selected for review and 96 days from submission to a Reviewed Preprint for those that are (2025), so a single blended number would hide a large gap. The 96-day figure ends at the first Reviewed Preprint, so it does not include any revision rounds or the time to a Version of Record.

An eLife desk-rejection risk and review delay check identifies desk-reject risk before you submit.